Freshpet (FRPT) director receives 1,589 restricted shares vesting in 2027

Rhea-AI Filing Summary

Kotcher Lauri Kien reported acquisition or exercise transactions in this Form 4 filing.

Freshpet, Inc. director Lauri Kien Kotcher received a grant of 1,589 shares of restricted common stock on March 10, 2026. These shares were awarded under the company’s 2024 Equity Incentive Plan and will vest on March 15, 2027, if she continues serving on the Board. Following this grant, she directly holds 5,067 common shares.

Insider Trade Summary

Net Buyer: 1,589 shares

Net Buy 1 txn

Insider Kotcher Lauri Kien

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,589	$0.00	$0.00

Holdings After Transaction: Common Stock — 5,067 shares (Direct)

Footnotes (1)

1. F1. The shares of restricted Common Stock were awarded to the Reporting Person under the Issuer's 2024 Equity Incentive Plan and vest on March 15, 2027, subject to the Reporting Person's continued service on the Board of Directors of the Issuer at such date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/12/2026 - 08:00 PM Learn about SEC filing dates

FAQ

What insider transaction did Freshpet (FRPT) report for Lauri Kien Kotcher?

Freshpet reported that director Lauri Kien Kotcher received a grant of 1,589 shares of restricted common stock. The award was made under the 2024 Equity Incentive Plan and reflects equity-based compensation rather than an open-market stock purchase or sale.

When do the newly granted Freshpet (FRPT) restricted shares vest?

The 1,589 restricted common shares granted to Lauri Kien Kotcher vest on March 15, 2027. Vesting is contingent on her continued service on Freshpet’s Board of Directors through that date, aligning her equity compensation with ongoing board responsibilities.

How many Freshpet (FRPT) shares does Lauri Kien Kotcher hold after this Form 4?

After the reported grant, Lauri Kien Kotcher directly holds 5,067 shares of Freshpet common stock. This figure includes the newly awarded 1,589 restricted shares reported in the filing as part of her equity compensation from the company.

Was the Freshpet (FRPT) Form 4 transaction a market buy or sell?

The Form 4 does not show a market buy or sell. Instead, it reports an acquisition coded as a grant or award of 1,589 restricted common shares, issued under Freshpet’s 2024 Equity Incentive Plan with no purchase price per share listed.

Under which plan was the Freshpet (FRPT) restricted stock granted?

The restricted common stock granted to Lauri Kien Kotcher was awarded under Freshpet’s 2024 Equity Incentive Plan. This plan provides for equity-based awards, and the reported shares are subject to vesting based on her continued board service through March 15, 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kotcher Lauri Kien

(Last) (First) (Middle)

C/O FRESHPET, INC.

1450 US-206

(Street)

BEDMINSTER NJ 07921

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A		1,589(1)	A	$0	5,067	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares of restricted Common Stock were awarded to the Reporting Person under the Issuer's 2024 Equity Incentive Plan and vest on March 15, 2027, subject to the Reporting Person's continued service on the Board of Directors of the Issuer at such date.

	/s/ Lisa A. Alexander, as Attorney-in-Fact for the Reporting Person	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.